Management of recurrent cervical papillary thyroid cancer. [Review]
Citation: Endocrinology & Metabolism Clinics of North America. 43(2):565-72, 2014 Jun.PMID: 24891178Institution: MedStar Washington Hospital CenterDepartment: Medicine/EndocrinologyForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: *Carcinoma, Papillary/th [Therapy] | *Neoplasm Recurrence, Local/th [Therapy] | *Thyroid Neoplasms/th [Therapy] | Carcinoma, Papillary/rt [Radiotherapy] | Carcinoma, Papillary/su [Surgery] | Humans | Lymph Nodes/su [Surgery] | Neoplasm Recurrence, Local/rt [Radiotherapy] | Neoplasm Recurrence, Local/su [Surgery] | Thyroid Neoplasms/rt [Radiotherapy] | Thyroid Neoplasms/su [Surgery]Local holdings: Available online from MWHC library: 1996 - presentISSN:- 0889-8529
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | Available | 24891178 |
Available online from MWHC library: 1996 - present
Papillary thyroid cancer is one of the most common endocrine malignancies, and it is often associated with an excellent prognosis. However, it has been shown to recur in the lymph nodes in the neck. The management of these lymph nodes remains controversial, and current treatment strategies include observation, surgery, radioactive iodine ablation, and percutaneous ethanol injection. These various treatment modalities are discussed in this article. Copyright � 2014 Elsevier Inc. All rights reserved.
English